Author:
Whitfield L. R.,Kaul P. N.,Clark M. L.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics
Reference22 articles.
1. S. H. Curry, J. M. Davis, D. S. Janowsky, and J. H. L. Marshall. Interpatient variation in physiological availability of chlorpromazine as a complicating factor in correlation studies of drug metabolism and clinical effect. In H. Corletti and F. S. Bove (eds.),The Present Status of Psychotropic Drugs, Excerpta Medica Foundation, Amsterdam, 1969, Chap. 2, pp. 72–76.
2. J. D. Maxwell, M. Carrella, J. D. Parks, R. Williams, G. P. Mould, and S. H. Curry. Plasma disappearance and cerebral effects of chlorpromazine in cirrhosis.Clin. Sci. 43:143–151 (1972).
3. L. E. Hollister and S. H. Curry. Urinary excretion of chlorpromazine metabolites following single doses and in steady-state conditions.Res. Commun. Chem. Pathol. Pharmacol. 2:330–338 (1971).
4. S. G. Dahl and R. E. Strandjord. Pharmacokinetics of chlorpromazine after single and chronic dosage.Clin. Pharmacol. Ther. 21:437–448 (1976).
5. L. E. Hollister, S. H. Curry, J. E. Derr, and S. L. Kanter. Studies of delayed action medication. V. Plasma levels and urinary excretion of four different dosage forms of chlorpromazine.Clin. Pharmacol. Ther. 11:49–59 (1970).
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献